Poultry Diagnostics Market Analysis

Poultry Diagnostics Market Analysis

To get key market trends

  Download Free Sample

Based on component, the market is classified as product and services. The product segment accounted for 60.4% market share in 2023. The product segment is further sub-segmented into kits & reagents and equipment & instruments.
 

• The highest growth of the products segment, inclusive of kits and reagents, is primarily due to its cost-effectiveness and immediate accessibility.
   
• The user-friendly design of many diagnostic kits enables farmers to perform tests without specialized training or equipment, empowering them to proactively monitor flock health.
   
• Additionally, products such as rapid test kits provide quick results, allowing farmers to identify and address health issues in real time, which is crucial for effective flock management.
   
• Therefore, these factors have significantly contributed to the growth and market share of the product segment in the poultry diagnostics industry.
   

Based on technology, the poultry diagnostics market is segmented into ELISA tests, PCR tests and other technologies. The ELISA tests segment dominated the market and was valued at USD 403.2 million in 2023.
 

• The high sensitivity and specificity of ELISA tests make them highly effective in detecting a wide range of pathogens in poultry. This efficiency, coupled with the ease of use and versatility of ELISA tests for multiple diseases, is driving segmental growth as poultry producers increasingly seek reliable diagnostic solutions.
   
• Another factor driving the growth of the ELISA tests segment is their ability to provide rapid results, enabling poultry farmers to quickly identify and address health issues.
   
• Recent advancements in ELISA technology, such as the development of more sensitive kits and automated systems, have enhanced their performance and efficiency. These innovations have further solidified ELISA's position as a preferred diagnostic tool in the poultry industry.
   

Based on disease type, the poultry diagnostics market is bifurcated into avian influenza, avian salmonellosis, Newcastle disease, avian mycoplasmosis, infectious bronchitis, infectious bursal disease, avian pasteurellosis, avian encephalomyelitis, avian reovirus, chicken anemia, and other diseases. The avian influenza segment is expected to grow at 10.8% during the analysis timeframe.
 

• Avian influenza is a highly contagious viral infection that poses a serious risk to both poultry and human populations. The frequent outbreaks of highly pathogenic strains have heightened the need for early detection and control, leading to increased investment in diagnostic tools and, consequently, driving market growth.
   
• Governments worldwide have implemented strict regulations to prevent the spread of avian influenza, mandating regular testing and surveillance in poultry farms. For instance, in India, the National Action Plan for Prevention, Control, and Containment of Avian Influenza has been formulated by the Department of Animal Husbandry and Dairying.
   
• These regulatory pressures are boosting demand for reliable and efficient diagnostic tools, thereby driving growth in the avian influenza diagnostics segment.
   
• Additionally, the rising global poultry trade and growing awareness of avian influenza's zoonotic potential further fuel demand for effective diagnostics to prevent cross-border transmission and protect both animal and human health.
   

Based on end use, the poultry diagnostics market is divided into veterinary hospitals & clinics, poultry farms and diagnostic laboratories. The veterinary hospitals & clinics segment in 2023 was valued at USD 323.8 million.
 

• The rising prevalence of poultry diseases, such as avian influenza, Newcastle disease, and Salmonella, has led to increased demand for specialized diagnostic services offered by veterinary hospitals and clinics.
   
• These facilities provide comprehensive diagnostic solutions, including advanced technologies like PCR and ELISA, which ensure accurate disease detection and foster growth in the segment.
   
• Additionally, the growing emphasis on biosecurity measures and early disease detection within the poultry industry has further heightened the need for veterinary services.
   
• As a result of these factors, the hospital segment is expected to continue dominating the global market.
   

In 2023, the U.S. poultry diagnostics market was valued at USD 257.8 million and is projected to reach USD 616.8 million by 2032.
 

• Poultry is the most consumed animal protein in the U.S., leading to significant production volumes and an increasing focus on maintaining flock health. The U.S. Department of Agriculture reports that nearly 15% of poultry meat produced in the country was exported in 2022, highlighting the importance of quality control and disease prevention to meet both domestic and international market demands.
   
• Furthermore, the rising incidence of poultry diseases, such as avian influenza and Salmonella, has intensified the need for effective diagnostic tools to ensure rapid detection and management.
   
• These factors collectively create a robust environment for the market, driving significant growth in the coming years.
   

Germany is expected to boost the growth of Europe poultry diagnostics market.
 

• As one of the largest poultry producers in Europe, Germany has a high demand for effective diagnostic solutions to ensure the health and productivity of its poultry farms.
   
• The country’s stringent food safety regulations drive the demand for advanced diagnostic technologies, while a strong emphasis on research and development fosters innovation in veterinary diagnostics.
   
• Additionally, Germany's proactive approach to managing zoonotic diseases and maintaining biosecurity enhances the importance of effective diagnostics, ensuring food safety and consumer confidence in poultry products.
   
• The aforementioned factors are expected to drive Germany's growth in the market.
   

China poultry diagnostics market is predicted to showcase remarkable growth over the forecast period.
 

• China market is anticipated to exhibit significant growth over the forecast period, driven by stable poultry production and increasing market dynamics.
   
• According to the U.S. Department of Agriculture, poultry production in China was expected to remain stable at 14.3 million metric tons in 2023, indicating robust and consistent demand for poultry products.
   
• Moreover, technological advancements in diagnostic methods and increasing investments in research and development by key industry players are expected to propel market growth in China.
   

Brazil held significant market position in the Latin America poultry diagnostics market.
 

• Research from the Center for Advice and Market Research (CEAP) reveals that chicken is favored in 94% of Brazilian households, while eggs are present in 96%, highlighting the country's strong reliance on poultry as a primary protein source.
   
• This high demand necessitates effective poultry health management, driving the need for advanced diagnostic solutions to monitor and control diseases.
   
• Furthermore, as the consumption of poultry has surged, surpassing traditional favorites like beef, which historically ranked as the second most consumed meat, Brazil’s focus on maintaining high production standards and food safety enhances the importance of reliable diagnostics.
   
• This combination of consumer preferences and the need for effective disease management positions Brazil as a leader in the market in Latin America.
   

Saudi Arabia poultry diagnostics market is projected to witness growth during forecast period.
 

• The market in Saudi Arabia is projected for significant growth due to the increasing demand for poultry products, driven by a rising population and consumer preferences for chicken as a primary protein source.
   
• Additionally, the shift toward modern farming practices, coupled with increased awareness of zoonotic diseases and the importance of maintaining animal health, further fuels the demand for effective diagnostics.